ATE181485T1 - Mit enantiomeren angereichertes, energiereiches nahrungsmittel - Google Patents

Mit enantiomeren angereichertes, energiereiches nahrungsmittel

Info

Publication number
ATE181485T1
ATE181485T1 AT96200875T AT96200875T ATE181485T1 AT E181485 T1 ATE181485 T1 AT E181485T1 AT 96200875 T AT96200875 T AT 96200875T AT 96200875 T AT96200875 T AT 96200875T AT E181485 T1 ATE181485 T1 AT E181485T1
Authority
AT
Austria
Prior art keywords
chiral
monoisomeric
alkanoates
enteral
acid esters
Prior art date
Application number
AT96200875T
Other languages
English (en)
Inventor
Patrick Francis Jonas
Xavier Leverve
David Eugene Pereira
Francis Rose
W Bruce Rowe
Susan L Trimbo
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Application granted granted Critical
Publication of ATE181485T1 publication Critical patent/ATE181485T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/675Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids of saturated hydroxy-carboxylic acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23DEDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00Other edible oils or fats, e.g. shortenings or cooking oils
    • A23D9/007Other edible oils or fats, e.g. shortenings or cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013Other fatty acid esters, e.g. phosphatides
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT96200875T 1995-04-06 1996-04-03 Mit enantiomeren angereichertes, energiereiches nahrungsmittel ATE181485T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/417,943 US6306828B1 (en) 1995-04-06 1995-04-06 Enantiomerically-enhanced nutritional energy substrates

Publications (1)

Publication Number Publication Date
ATE181485T1 true ATE181485T1 (de) 1999-07-15

Family

ID=23655996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96200875T ATE181485T1 (de) 1995-04-06 1996-04-03 Mit enantiomeren angereichertes, energiereiches nahrungsmittel

Country Status (10)

Country Link
US (1) US6306828B1 (de)
EP (1) EP0736256B1 (de)
JP (1) JPH08283163A (de)
AT (1) ATE181485T1 (de)
AU (1) AU707531B2 (de)
CA (1) CA2173270A1 (de)
DE (1) DE69602985T2 (de)
DK (1) DK0736256T3 (de)
ES (1) ES2138284T3 (de)
GR (1) GR3031086T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6482853B1 (en) * 2000-07-12 2002-11-19 George A. Brooks Lactate thiolester for cardiac energy resuscitation and prevention of reperfusion injury and use as an energy supplement during exercise and recovery
NZ543201A (en) * 2003-05-01 2007-05-31 Innogene Kalbiotech Pte Ltd Lactate containing pharmaceutical composition and uses thereof
AU2004245567B2 (en) 2003-06-03 2011-06-23 Oxford University Innovation Limited Nutritional supplements and therapeutic compositions comprising (R)-3-hydroxybutyrate derivatives
EP2240017B1 (de) 2008-01-04 2019-03-13 Oxford University Innovation Limited Ketonkörper und ketonkörperester als blutfettsenkende mittel
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
JP6883384B2 (ja) 2012-11-05 2021-06-09 ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ 電離放射線による傷害から組織を防護するためのケトン体
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
SG11201507685UA (en) 2013-03-14 2015-10-29 Isis Innovation Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate
EP3043788B1 (de) * 2013-09-13 2023-06-07 Replicon Health OY D-glycerinsäure oder dl-glycerinsäure zur verwendung bei der behandlung von altersbedingten degenerationskrankheiten
JP7235873B2 (ja) 2019-01-17 2023-03-08 アイオーアイ オレオ ゲーエムベーハー ヒドロキシカルボン酸のグリセリドの製造方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5195121A (en) * 1975-02-19 1976-08-20 Urogasutoronno shokakankyushuseizodaiho
JPS5334713A (en) 1976-09-09 1978-03-31 Nishikawa Yoshi Method of manufacturing 11lauroyll glucopyranose
JPS5334712A (en) 1976-09-09 1978-03-31 Nishikawa Yoshi Method of manufacturing 11stearoyll glucopyranose
US4107425A (en) * 1977-02-15 1978-08-15 The United States Of America As Represented By The Secretary Of Agriculture Preparation of 1-α- and 1-β-glucose esters by stereoselective acylation of metalated 2,3,4,6,-tetra-O-benzyl-D-glucopyranose
US4675177A (en) * 1980-10-09 1987-06-23 American Cyanamid Company Antiperspirant compositions
US4665057A (en) 1983-03-22 1987-05-12 Deanna Nelson Nutrient monoesters
US4701443A (en) 1983-03-22 1987-10-20 Baxter Travenol Laboratories, Inc. Nutrient polyesters
US4753963A (en) * 1985-09-26 1988-06-28 The Procter & Gamble Company Nutritional fat suitable for enteral and parenteral products
JPH0667833B2 (ja) * 1985-11-28 1994-08-31 雪印乳業株式会社 経腸栄養剤
GB8620896D0 (en) * 1986-08-29 1986-10-08 Unilever Plc Cosmetic composition
GB8809421D0 (en) * 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
JPH0651692B2 (ja) * 1989-06-01 1994-07-06 ダイソー株式会社 光学活性化合物
JPH0383950A (ja) * 1989-08-28 1991-04-09 Kanegafuchi Chem Ind Co Ltd グリセリド誘導体およびその製造法
EP0465689B1 (de) 1990-07-09 1994-02-02 Societe Des Produits Nestle S.A. Kalorienarme Nahrungsmittelzusammenstellung
US5256697A (en) 1992-04-16 1993-10-26 Abbott Laboratories Method of administering pyruvate and methods of synthesizing pyruvate precursors
US5308832A (en) 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
US5263260A (en) 1992-08-03 1993-11-23 Smith Lee R Tile leveler and method
ATE175444T1 (de) * 1992-10-29 1999-01-15 Loders Croklaan Bv Enzymatisches triglycerid-umsetzverfahren
WO1995009144A1 (en) * 1993-09-30 1995-04-06 Eastman Chemical Company Nutritive water soluble glycerol esters of hydroxy butyric acid

Also Published As

Publication number Publication date
EP0736256A1 (de) 1996-10-09
US6306828B1 (en) 2001-10-23
EP0736256B1 (de) 1999-06-23
JPH08283163A (ja) 1996-10-29
AU5045696A (en) 1996-10-17
DK0736256T3 (da) 1999-11-22
CA2173270A1 (en) 1996-10-07
AU707531B2 (en) 1999-07-15
GR3031086T3 (en) 1999-12-31
DE69602985D1 (de) 1999-07-29
ES2138284T3 (es) 2000-01-01
DE69602985T2 (de) 2000-02-17

Similar Documents

Publication Publication Date Title
JP3967388B2 (ja) 改良された口当たり性を有する経口的に摂取可能な栄養組成物
DE69602985D1 (de) Mit Enantiomeren angereichertes, energiereiches Nahrungsmittel
US3849554A (en) Reduction of blood serum cholesterol
TW200744463A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
DK0515460T3 (da) Docosahexaensyre, fremgangsmåder til fremstilling deraf og forbindelser indeholdende samme
CA2244608A1 (en) Nutritional product with high fat, low carbohydrate and amino acid imbalance
CA2405822A1 (en) Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
FR2714574B1 (fr) Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
GR3032548T3 (en) Nutrition for persons undergoing radiation therapy and/or chemotherapy.
ATE148920T1 (de) Verfahren zur enzymatischen herstellung von alpha-sialylierten oligosaccharid-glykosiden
DK0754001T3 (da) Næringsmiddelprodukt til behandling af colitis ulcerosa og anvendelse deraf
AU652785B2 (en) Nutrition
NO984859D0 (no) Additiv for anvendelse i et energitilskudd, anvendelse av et proteinhydrolysat for fremstilling av energitilskudd inneholdende et slikt additiv
AU2002305011A1 (en) Enzyme treated maple syrup, shelf stable, pure maple based products, and blended products
CA2100774A1 (en) Feed additive and method
DE69205562D1 (de) Dicarbonsäure-derivate von 6-12 kohlenstoffatomen sowie anwendung dieser derivate sowie der freien dicarbonsäuren zur herstellung von arzneimitteln zur enteralen und parenteralen ernährung.
Bitutskaya et al. Functional food compositions using spirulina for the production of health jelly
And et al. Essential fatty acids in human colostrum
Yeh Specific nutrient: role of arginine in sepsis
Rao et al. Nutritional inadequacy of lieber-decarli alcohol diet
LAWAN et al. Amount of n-3 fatty acid in freshwater fish found in Northeast Thailand
CAI et al. The effects and the mechanisms of exogenous fatty acids on colorectal cancer cells
Winitz Reduction of blood serum cholesterol
JPS6474995A (en) Production of prostaglandin
Sandanov et al. Characteristics of central metabolism in coryneform bacteria